Cytoplasmic FBXO38 mediates PD-1 degradation ( vol 25 , pg 4168 , 2024)

被引:0
|
作者
Liu, Xiwei
Meng, Xiangbo
Lin, Zuomiao
Jiang, Shutan
Liu, Haifeng
Sun, Shao-cong
Liu, Xiaolong
Zhou, Penghui
Huang, Xiaowu
Wei, Lai
Yang, Wei
Xu, Chenqi
机构
关键词
D O I
10.1038/s44319-024-00298-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:5838 / 5838
页数:1
相关论文
共 50 条
  • [31] Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer (vol 5, pg 131, 2019)
    Tu, Megan M.
    Ng, Terry L.
    De Jong, Florus C.
    Zuiverloon, Tahlita C. M.
    Fazzari, Francesco G. T.
    Theodorescu, Dan
    BLADDER CANCER, 2020, 6 (04) : 559 - 559
  • [32] PD-L1 inhibits acute and chronic pain by suppressing nociceptive neuron activity via PD-1 (vol 20, pg 917, 2017)
    Chen, Gang
    Kim, Yong Ho
    Li, Hui
    Luo, Hao
    Liu, Da-Lu
    Zhang, Zhi-Jun
    Lay, Mark
    Chang, Wonseok
    Zhang, Yu-Qiu
    Ji, Ru-Rong
    NATURE NEUROSCIENCE, 2019, 22 (03) : 503 - 503
  • [33] Molecular Biomarkers of Response to PD-1/PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer (vol 6, pg 559, 2020)
    Tu, Megan M.
    Ng, Terry L.
    De Jong, Florus C.
    Zuiverloon, Tahlita C. M.
    Fazzari, Francesco G. T.
    Theodorescu, Dan
    BLADDER CANCER, 2021, 7 (01) : 109 - 109
  • [34] PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease (vol 14, 1326078, 2024)
    Kocheise, Lorenz
    Piseddu, Ignazio
    Vonderlin, Joscha
    Tjwa, Eric T.
    Buescher, Gustav
    Meunier, Lucy
    Goeggelmann, Pia
    Fianchi, Francesca
    Dumortier, Jerome
    Barciela, Mar Riveiro
    Gevers, Tom J. G.
    Beretta-Piccoli, Benedetta Terziroli
    Londono, Maria-Carlota
    Frankova, Sona
    Roesner, Thomas
    Joerg, Vincent
    Schmidt, Constantin
    Glaser, Fabian
    Sutter, Jan P.
    Fruendt, Thorben W.
    Lohse, Ansgar W.
    Huber, Samuel
    von Felden, Johann
    Sebode, Marcial
    Schulze, Kornelius
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [35] Silencing PD-1 and PD-L1: the potential of PolyPurine Reverse Hoogsteen hairpins for the elimination of tumor cells (vol 11, pg 369 2019)
    Ciudad, Carlos J.
    Enriquez, Mariam Marlene Medina
    Felix, Alex J.
    Bener, Gizem
    Noe, Veronique
    IMMUNOTHERAPY, 2019, 11 (07) : 645 - 645
  • [36] PD-1 deficiency protects experimental colitis via alteration of gut microbiota (vol 50, pg 578, 2017)
    Park, Seong Jeong
    Kim, Ji-Hae
    Song, Mi-Young
    Sung, Young Chul
    Lee, Seung-Woo
    Park, Yunji
    BMB REPORTS, 2018, 51 (06) : 314 - 314
  • [37] Thermal degradation kinetics and reaction mechanisms of HDPE and PS plastic wastes using a micro combustion calorimeter ( vol 38, pg 7007, 2024)
    Handawy, Mohamed K. M.
    Im, Ik-Tae
    Abdelmotalib, Hamada Mohamed
    JOURNAL OF MECHANICAL SCIENCE AND TECHNOLOGY, 2025, 39 (01) : 477 - 477
  • [38] Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy (vol 25, pg 290, 2019)
    Passaro, Carmela
    Alayo, Quazim
    DeLaura, Isabel
    McNulty, John
    Grauwet, Korneel
    Ito, Hirotaka
    Bhaskaran, Vivek
    Mineo, Marco
    Lawler, Sean E.
    Shah, Khalid
    Speranza, Maria C.
    Goins, William
    McLaughlin, Eric
    Fernandez, Soledad
    Reardon, David A.
    Freeman, Gordon J.
    Chiocca, E. Antonio
    Nakashima, Hiroshi
    CLINICAL CANCER RESEARCH, 2020, 26 (03) : 758 - 758
  • [39] Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma (vol 12, pg 1, 2020)
    Ran, X.
    Xiao, J.
    Zhang, Y.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [40] PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy (vol 128, pg 1413, 2018)
    Zamarin, Dmitriy
    Ricca, Jacob M.
    Sadekova, Svetlana
    Oseledchyk, Anton
    Yu, Ying
    Blumenschein, Wendy M.
    Wong, Jerelyn
    Gigoux, Mathieu
    Merghoub, Taha
    Wolchok, Jedd D.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (11): : 5184 - 5184